1X80 Stock Overview
Melodiol Global Health Limited develops, registers, and commercializes pharmaceutical-grade cannabis, and hemp-based nutraceutical products and treatments for human and other health in Europe, Canada, the Asia Pacific, the United States, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Melodiol Global Health Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$0.01 |
| 52 Week High | AU$0.18 |
| 52 Week Low | AU$0.002 |
| Beta | 2.55 |
| 1 Month Change | 0% |
| 3 Month Change | 0% |
| 1 Year Change | -85.71% |
| 3 Year Change | -99.62% |
| 5 Year Change | -99.81% |
| Change since IPO | -99.86% |
Recent News & Updates
Recent updates
Shareholder Returns
| 1X80 | DE Pharmaceuticals | DE Market | |
|---|---|---|---|
| 7D | 0% | -2.9% | -2.5% |
| 1Y | -85.7% | -31.3% | -0.4% |
Return vs Industry: 1X80 underperformed the German Pharmaceuticals industry which returned -31.3% over the past year.
Return vs Market: 1X80 underperformed the German Market which returned -0.4% over the past year.
Price Volatility
| 1X80 volatility | |
|---|---|
| 1X80 Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 7.0% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in DE Market | 9.9% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 1X80 has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine 1X80's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2015 | n/a | Will Lay | melodiolglobalhealth.com |
Melodiol Global Health Limited develops, registers, and commercializes pharmaceutical-grade cannabis, and hemp-based nutraceutical products and treatments for human and other health in Europe, Canada, the Asia Pacific, the United States, and internationally. The company develops and commercializes therapeutic products; develops and sells beauty and personal care products under the Green Goo, Southern Butter, and Goodgoo brands; and cultivates, processes, and sells cannabis products. Its products include cannaQIX, a nutraceutical product containing hemp oil extract, and vitamins and minerals in a lozenge delivery system; the ImpACTIVE Pro Releaf Stick to provide relief to muscle aches, particularly in professional sport, and acts as an alternative to pharmacological solutions sold through online channels; Ritual Green, a dried flower; Ritual Sticks for pre-rolled joints; and Ritual Gold, a handheld vapouriser.
Melodiol Global Health Limited Fundamentals Summary
| 1X80 fundamental statistics | |
|---|---|
| Market cap | €1.30m |
| Earnings (TTM) | -€21.45m |
| Revenue (TTM) | €11.42m |
0.1x
P/S Ratio-0.1x
P/E RatioIs 1X80 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 1X80 income statement (TTM) | |
|---|---|
| Revenue | AU$18.92m |
| Cost of Revenue | AU$18.10m |
| Gross Profit | AU$817.00k |
| Other Expenses | AU$36.34m |
| Earnings | -AU$35.52m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.066 |
| Gross Margin | 4.32% |
| Net Profit Margin | -187.73% |
| Debt/Equity Ratio | -232.0% |
How did 1X80 perform over the long term?
See historical performance and comparison